RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Phase 2 Recruiting
100 enrolled
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
Phase 1 Recruiting
52 enrolled
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Phase 1 Recruiting
32 enrolled
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
Phase 1 Recruiting
120 enrolled
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
Phase 2 Completed
18 enrolled
QUANTUM
Enrolling by invitation
3,000 enrolled
An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer
Phase NA Completed
194 enrolled
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Recruiting
20,000 enrolled
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
EMBOLD
Phase 1/2 Terminated
134 enrolled
BETAPREDICT
Completed
162 enrolled
Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms
Phase NA Completed
114 enrolled
An Observational Post-Marketing Safety Registry of Sativex®
Completed
978 enrolled
PROmyBETAapp
Completed
96 enrolled
Central Pain Study for ABX-1431
Phase 1 Completed
9 enrolled
ASCEND in SPMS
Phase 3 Terminated
889 enrolled 31 charts